Increased arterial distensibility in postmenopausal hypertensive women with and without hormone replacement therapy after acute administration of the ACE-inhibitor moexipril

Cardiovascular Drugs and Therapy

Volumn 12, Issue 4, 1998, Pages 409-414

  Blacher, Jacques ^a   Raison, Jocelyne ^a   Amah, Guy ^a   Schiemann, Anne Liv ^b   Stimpel, Michael ^b   Safar, Michel E ^a  

^a HÔPITAL BROUSSAIS   (France)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Arterial compliance; Carotid femoral pulse wave velocity; Hormone replacement therapy; HRT; Moexipril

Indexed keywords

ALDOSTERONE; CHLORMADINONE ACETATE; ESTRADIOL; MOEXIPRIL; RENIN;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTERY COMPLIANCE; ARTERY DILATATION; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ESSENTIAL HYPERTENSION; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PLASMA RENIN ACTIVITY; POSTMENOPAUSE; PRIORITY JOURNAL; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; TRANSDERMAL DRUG ADMINISTRATION;

ALDOSTERONE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HEART RATE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPERTENSION; ISOQUINOLINES; MIDDLE AGED; POSTMENOPAUSE; RENIN; TETRAHYDROISOQUINOLINES; TIME FACTORS; VASCULAR RESISTANCE;

EID: 0031755755     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007733103730     Document Type: Article

References (27)

1. Rajkumar C, Kingwell BA, Cameron JD, Waddel T, Mehra R, Christophidis N, Komesaroff PA, McGrath B, Jennings GL, Sudhir K, Dart AM. Hormonal therapy increases arterial compliance in postmenauposal women. J Am Coll Cardiol 1997;30:350-356.
2. Taddei S, Virdis A, Ghiadoni L, Mattei P, Sudano I, Bemini G, Pinto S, Salvetti A. Menopause is associated with endothelial dysfunction in women. Hypertension 1996;28:576-582.
3. London GM, Guerin AP, Pannier K, Marchais SJ, Benetos A, Safar ME. Influence of sex on arterial hemodynamics and blood pressure. Role of body height. Hypertension 1995;26: 514-519.
4. Wolinski H. Effects of estrogen and progesterone treatment on the response of the aorta of male rats to hypertension. Morphological and chemical studies. Circ Res 1972;30:341-394.
5. Fischer GM. In vivo effects of estradiol on collagen and elastin dynamics in rat aorta. Endocrinology 1972;91:1227-1232.
6. Safar ME, Asmar RG, Benetos A. Large artery dilation produced by converting enzyme inhibition in hypertension: Therapeutic aspects. Am J Med 1992;92(Suppl. 4B):47-53.
7. Safar ME. Antihypertensive effects of nitrates in chronic human hypertension. J Appl Cardiol 1990;5:69-81.
8. Darne BE, Girerd X, Safar M, Cambien Y, Guize L. Pulsatile versus steady component of blood pressure: A cross-sectional analysis and a prospective analysis on cardiovascular mortality. Hypertension 1989;13:392-400.
9. Safar ME, Levy BI, Laurent ST, London GM. Hypertension and the arterial system: Clinical and therapeutic aspects. J Hypertens 1990;8(Suppl. 7):S113-S119.
10. Stimpel M, Cawello W. Pharmacokineties and ACE-inhibition of the new ACE-inhibitor moexipril: Is coadministration with food of clinical relevance? Hypertension 1995;26: 1384-1396.
11. Stimpel M, Koch B. Moexipril versus placebo in postmenopausal women receiving HRT. Hypertension 1997;29: 843-851.
12. Stimpel M, Bonn R, Koch B, Dickstein K. Pharmacology and clinical use of the new ACE-inhibitor moexipril. Cardiovasc Drug Rev 1995;13:211-229.
13. Edling O, Bao G, Feelisch M, Unger T, Gohlke P. Moexipril, a new angiotensin converting enzyme (ACE) inhibitor: Pharmacological characterization and comparison with enalapril. J Pharmacol Exp Ther 1995;275:854-863.
14. White WB, Whelton A, Fox AAL, Stimpel M, Kaihlanen PM. Tricenter assessment of the efficacy and pharmacodynamics of the ACE-inhibitor, moexipril, by ambulatory blood pressure monitoring. J Clin Pharmacol 1995;35:233-238.
15. Koch B, Stimpel M, Andersson O. Low-dose combinations of moexipril and hydrochlorothiazide in the treatment of hypertension. Pharmacol Res 1995;31(Suppl.):328-337.
16. Asmar RG, Benetos A, Topouchian J, et al. Assessment of arterial compliance by automatic PWV measurements. Validation and clinical application studies. Hypertension 1995; 26:485-490.
17. Asmar RG, Benetos A, Darne HM, Pauly NC, Safar ME. Converting enzyme inhibition: Dissociation between antihypertensive and arterial effects. J Hum Hypertens 1992;6: 381-385.
18. Scalbert K, Levy B, Desche P, Devissaguet M, Safar ME. Vascular effects of perindopril: From experimental to clinical investigation. J Cardiovasc Pharmacol 1991;18(Suppl. 7):S25-S32.
19. Asmar RG, Iannascoli F, Benetos A, Safar ME. Dose optimization study of arterial changes associated with angiotensin converting inhibition in hypertension. J Hypertens 1992;10 (Suppl. 5):S13-S19.
20. Benetos A, Vasmant D, Thiery P, Safar ME. Effects of ramipril on arterial hemodynamics. J Cardiovasc Pharmacol 1991;18(Suppl. 2):S153-S156.
21. London G, Courivaux JM, Stimpel M, Safar ME. Arterial stiffness and extracellular matrix in ovariectomized female spontaneously hypertensive rats. In: Stimpel M, Zanchetti A, eds. Hypertension After menopause. Berlin: de Gruyte, 1997:113-123.
22. Benetos A, Levy BI, Lacolley P, Taillard F, Duriez M, Safar ME. Role of angiotensin II and bradykinin on aortic collagen following converting enzyme inhibition in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 1997;17: 3196-3201.
23. Pang SC, Greendale GA, Cedars MI, Gambone JC, Lozano K, Eggana P, Judd HL. Long term effects of transdermal estradiol with and without medroxyprogesterone acetate. Fertil Steril 1993;59:76-82.
24. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on the heart disease risk factors in postmenopausal women. JAMA 1995;273:199-208.
25. Mendelsohn ME, Karas RH. Estrogen and the blood vessel wall. Curr Opin Cardiol 1994;9:619-626.
26. Schunkert H, Danser AHJ, Hense HW, Derkx FHM, Kürzinger S, Riegger GAG. Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation 1997;95:39-45.
27. Proudler AJ, Ahmed ALH, Crook D, Fogelman I, Rymer JM, Stevenson JC. Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women. Lancet 1995;346:89-90.